ASPM and large cell neuroendocrine carcinoma: Our results showed that ASPM was significantly higher expressed in SCLC than in LCNEC (Student’s t test, p < 0.0001), indicating that ASPM might be a therapeutic target for SCLC (Zhang et al., 2015).